BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 29
• 30

• MorphoSys AG Unveils New Antibody Library, HuCAL PLATINUM(r)

  December 9, 2008

   · 

  1 min read
• Drug Development

  Portola Pharmaceuticals, Inc. Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention

  December 9, 2008

   · 

  4 min read
• Drug Development

  Omeros Corporation Announces Results from a Phase 1 Study of OMS201 for Use During Urological Surgery

  December 9, 2008

   · 

  2 min read
• Drug Development

  Micromet Presents Updated Data on the Phase 1 Trial Studying Blinatumomab (MT103/MEDI-538) in Patients with Advanced Non-Hodgkin’s Lymphoma

  December 9, 2008

   · 

  6 min read
• Drug Development

  EntreMed, Inc. Initiates ENMD-2076 Clinical Trial in Multiple Myeloma Phase 1 Trial Supported by Preclinical Data Presented at the American Society of Hematology Meeting

  December 9, 2008

   · 

  5 min read
• Drug Development

  UCB Group New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures

  December 9, 2008

   · 

  8 min read
• Drug Development

  Senesco Technologies, Inc.'s Preclinical Multiple Myeloma Data Presented at the 50th Annual Meeting of the American Society of Hematology

  December 9, 2008

   · 

  3 min read
• Drug Development

  Nile Therapeutics, Inc. Announces Positive Results from Phase 1b Safety and Pharmacodynamics Study of CD-NP in Patients with Heart Failure

  December 9, 2008

   · 

  7 min read
• Drug Development

  Bayer HealthCare Pharmaceuticals Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL

  December 9, 2008

   · 

  13 min read
• Job Trends

  XTL Biopharmaceuticals Ltd. Implements Restructuring Plan; Terminating Employment of 75% of Workforce

  December 9, 2008

   · 

  1 min read